These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17846228)

  • 41. Protein kinase C-theta mediates a selective T cell survival signal via phosphorylation of BAD.
    Villalba M; Bushway P; Altman A
    J Immunol; 2001 May; 166(10):5955-63. PubMed ID: 11342610
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PRKCQ promotes oncogenic growth and anoikis resistance of a subset of triple-negative breast cancer cells.
    Byerly J; Halstead-Nussloch G; Ito K; Katsyv I; Irie HY
    Breast Cancer Res; 2016 Sep; 18(1):95. PubMed ID: 27663795
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergistic action of protein kinase C theta and calcineurin is sufficient for Fas ligand expression and induction of a crmA-sensitive apoptosis pathway in Jurkat T cells.
    Villunger A; Ghaffari-Tabrizi N; Tinhofer I; Krumböck N; Bauer B; Schneider T; Kasibhatla S; Greil R; Baier-Bitterlich G; Uberall F; Green DR; Baier G
    Eur J Immunol; 1999 Nov; 29(11):3549-61. PubMed ID: 10556809
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PKCtheta and PKA are antagonistic partners in the NF-AT transactivation pathway of primary mouse CD3+ T lymphocytes.
    Hermann-Kleiter N; Thuille N; Pfeifhofer C; Gruber T; Schäfer M; Zitt C; Hatzelmann A; Schudt C; Leitges M; Baier G
    Blood; 2006 Jun; 107(12):4841-8. PubMed ID: 16514061
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protein kinase Ctheta focusing at the cSMAC is a consequence rather than cause of TCR signaling and is dependent on the MEK/ERK pathway.
    Praveen K; Zheng Y; Rivas F; Gajewski TF
    J Immunol; 2009 May; 182(10):6022-30. PubMed ID: 19414753
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of type I protein kinase A during receptor-mediated human T lymphocyte activation.
    Laxminarayana D; Kammer GM
    J Immunol; 1996 Jan; 156(2):497-506. PubMed ID: 8543799
    [TBL] [Abstract][Full Text] [Related]  

  • 47. T Cell Leukemia/Lymphoma 1A is essential for mouse epidermal keratinocytes proliferation promoted by insulin-like growth factor 1.
    Bresin A; Ragone G; Cristofoletti C; Arcelli D; Bassi C; Caprini E; Fiorenza MT; Helmer Citterich M; Russo G; Narducci MG
    PLoS One; 2018; 13(10):e0204775. PubMed ID: 30286151
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.
    Kumar R; Tripathi V; Ahmad M; Nath N; Mir RA; Chauhan SS; Luthra K
    Cell Immunol; 2012; 272(2):230-41. PubMed ID: 22070874
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stephanthraniline A suppressed CD4(+) T cell-mediated immunological hepatitis through impairing PKCθ function.
    Chen FY; Zhou LF; Li XY; Zhao JW; Xu SF; Huang WH; Gao LJ; Hao SJ; Ye YP; Sun HX
    Eur J Pharmacol; 2016 Oct; 789():370-384. PubMed ID: 27448502
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PKCtheta and Itk functionally interact during primary mouse CD3+ T cell activation.
    Thuille N; Lutz-Nicoladoni C; Letschka T; Hermann-Kleiter N; Heit I; Baier G
    Immunol Lett; 2009 Sep; 126(1-2):54-9. PubMed ID: 19682494
    [TBL] [Abstract][Full Text] [Related]  

  • 51. AKT-pathway inhibition in chronic lymphocytic leukemia reveals response relationships defined by TCL1.
    Schrader A; Popal W; Lilienthal N; Crispatzu G; Mayer P; Jones D; Hallek M; Herling M
    Curr Cancer Drug Targets; 2014; 14(8):700-12. PubMed ID: 25348018
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of karyotyping,
    Sun Y; Tang G; Hu Z; Thakral B; Miranda RN; Medeiros LJ; Wang SA
    J Clin Pathol; 2018 Apr; 71(4):309-315. PubMed ID: 28821581
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Crystal structures of Tcl1 family oncoproteins and their conserved surface features.
    Petock JM; Torshin IY; Wang YF; Du Bois GC; Croce CM; Harrison RW; Weber IT
    ScientificWorldJournal; 2002 Jul; 2():1876-84. PubMed ID: 12920316
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual role of H-Ras in regulation of lymphocyte function antigen-1 activity by stromal cell-derived factor-1alpha: implications for leukocyte transmigration.
    Weber KS; Ostermann G; Zernecke A; Schröder A; Klickstein LB; Weber C
    Mol Biol Cell; 2001 Oct; 12(10):3074-86. PubMed ID: 11598192
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of the TCL1/MTCP1-like 1 (TML1) gene from the region next to the TCL1 locus.
    Sugimoto J; Hatakeyama T; Narducci MG; Russo G; Isobe M
    Cancer Res; 1999 May; 59(10):2313-7. PubMed ID: 10344735
    [TBL] [Abstract][Full Text] [Related]  

  • 56. TORC2 regulates germinal center repression of the TCL1 oncoprotein to promote B cell development and inhibit transformation.
    Kuraishy AI; French SW; Sherman M; Herling M; Jones D; Wall R; Teitell MA
    Proc Natl Acad Sci U S A; 2007 Jun; 104(24):10175-80. PubMed ID: 17548807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of AS2521780, a novel PKCθ selective inhibitor, on T cell-mediated immunity.
    Fukahori H; Chida N; Maeda M; Tasaki M; Kawashima T; Matsuoka H; Suzuki K; Ishikawa T; Tanaka A; Higashi Y
    Eur J Pharmacol; 2014 Dec; 745():217-22. PubMed ID: 25445039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel PKC regulates ERK activation and degranulation of cytotoxic T lymphocytes: Plasticity in PKC regulation of ERK.
    Puente LG; He JS; Ostergaard HL
    Eur J Immunol; 2006 Apr; 36(4):1009-18. PubMed ID: 16552708
    [TBL] [Abstract][Full Text] [Related]  

  • 59. PKC mediates fluctuant ERK-paxillin signaling for hepatocyte growth factor-induced migration of hepatoma cell HepG2.
    Hu CT; Cheng CC; Pan SM; Wu JR; Wu WS
    Cell Signal; 2013 Jun; 25(6):1457-67. PubMed ID: 23524339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proto-oncogene TCL1: more than just a coactivator for Akt.
    Noguchi M; Ropars V; Roumestand C; Suizu F
    FASEB J; 2007 Aug; 21(10):2273-84. PubMed ID: 17360849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.